{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:13:44Z","timestamp":1787876024427,"version":"build-2784847793"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.jaad.2020.04.013","type":"journal-article","created":{"date-parts":[[2020,4,11]],"date-time":"2020-04-11T19:21:53Z","timestamp":1586632913000},"page":"345-352","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Limited utility of repeated vital sign monitoring during initiation of oral propranolol for complicated infantile hemangioma"],"prefix":"10.1016","volume":"85","author":[{"given":"Katherine B.","family":"P\u00fcttgen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leanna M.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Lauren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Stefanko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Mathes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerilyn M.","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megha M.","family":"Tollefson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eulalia","family":"Baselga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Chamlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Corey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flora F.","family":"Frascari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilona J.","family":"Frieden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloise R.","family":"Galligan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepti","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Haggstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Horii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph P.","family":"Hornik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justyna","family":"Klajn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Liberman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Mancini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Mannschreck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anelah","family":"McGinness","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"McCuaig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Newell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Nopper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tola","family":"Oyesanya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Rios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn H.","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kendra","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"Garzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Frommelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth A.","family":"Drolet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/j.jaad.2020.04.013_bib1","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1056\/NEJMc0708819","article-title":"Propranolol for severe hemangiomas of infancy","volume":"358","author":"L\u00e9aut\u00e9-Labr\u00e8ze","year":"2008","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jaad.2020.04.013_bib2","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1542\/peds.2012-1691","article-title":"Initiation and use of propranolol for infantile hemangioma: report of a consensus conference","volume":"131","author":"Drolet","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaad.2020.04.013_bib3","series-title":"Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0","year":"2017"},{"key":"10.1016\/j.jaad.2020.04.013_bib4","series-title":"Handbook of Emergency Cardiovascular Care for Healthcare Providers","year":"2015"},{"key":"10.1016\/j.jaad.2020.04.013_bib5","first-page":"I-291","article-title":"ECC guidelines part 10: pediatric advanced life support Circulation","volume":"102","year":"2000"},{"issue":"9770","key":"10.1016\/j.jaad.2020.04.013_bib6","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0140-6736(10)62226-X","article-title":"Normal ranges of heart rate and respiratory rate in children from birth to 18 years of age: a systematic review of observational studies","volume":"377","author":"Fleming","year":"2011","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jaad.2020.04.013_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.79.1.1","article-title":"Report of the Second Task Force on Blood Pressure Control in Children--1987. Task Force on Blood Pressure Control in Children. National Heart, Lung, and Blood Institute, Bethesda, Maryland","volume":"79","year":"1987","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.jaad.2020.04.013_bib8","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/bjd.16779","article-title":"Oral propranolol in the treatment of proliferating infantile haemangiomas: British Society for Paediatric Dermatology consensus guidelines","volume":"179","author":"Solman","year":"2018","journal-title":"Br J Dermatol"},{"issue":"11","key":"10.1016\/j.jaad.2020.04.013_bib9","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1111\/jdv.14955","article-title":"Safety profile during initiation of propranolol for treatment of infantile haemangiomas in an ambulatory day-care hospitalization setting","volume":"32","author":"Fogel","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.jaad.2020.04.013_bib10","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1038\/s41598-017-01321-2","article-title":"Safety and tolerance of propranolol in neonates with severe infantile hemangiomas: a prospective study","volume":"7","author":"Ji","year":"2017","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.jaad.2020.04.013_bib11","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/pde.12182","article-title":"Twenty-four-hour hospitalization for patients initiating systemic propranolol therapy for infantile hemangiomas--is it indicated?","volume":"30","author":"Liu","year":"2013","journal-title":"Pediatr Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2020.04.013_bib12","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1080\/09546634.2016.1277177","article-title":"Oral propranolol for infantile hemangiomas: a prospective study on the role of 48-hour Holter monitoring in additional safety assessment","volume":"28","author":"Petrovic","year":"2017","journal-title":"J Dermatol Treat"},{"issue":"1-2","key":"10.1016\/j.jaad.2020.04.013_bib13","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000450755","article-title":"Cardiovascular profile of propranolol after multiple dosing in infantile hemangioma","volume":"99","author":"Salice","year":"2017","journal-title":"Pharmacology"},{"issue":"2","key":"10.1016\/j.jaad.2020.04.013_bib14","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jaad.2015.05.015","article-title":"Experience with Holter monitoring during propranolol therapy for infantile hemangiomas","volume":"73","author":"Jacks","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2020.04.013_bib15","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/ajd.12600","article-title":"Consensus statement for the treatment of infantile haemangiomas with propranolol","volume":"58","author":"Smithson","year":"2017","journal-title":"Australas J Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2020.04.013_bib16","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1056\/NEJMoa1404710","article-title":"A randomized, controlled trial of oral propranolol in infantile hemangioma","volume":"372","author":"L\u00e9aut\u00e9-Labr\u00e8ze","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2020.04.013_bib17","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/pde.12681","article-title":"Blood pressure monitoring during the induction and maintenance period of propranolol therapy for complicated infantile hemangiomas: a prospective study of 109 infants","volume":"32","author":"Hengst","year":"2015","journal-title":"Pediatr Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2020.04.013_bib18","doi-asserted-by":"crossref","first-page":"e20160353","DOI":"10.1542\/peds.2016-0353","article-title":"Safety of oral propranolol for the treatment of infantile hemangioma: a systematic review","volume":"138","author":"L\u00e9aute-Labr\u00e8ze","year":"2016","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.jaad.2020.04.013_bib19","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/pde.12089","article-title":"Propranolol and infantile hemangiomas four years later: a systematic review","volume":"30","author":"Marqueling","year":"2013","journal-title":"Pediatr Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2020.04.013_bib20","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1001\/jama.2015.13969","article-title":"Safety of propranolol therapy for severe infantile hemangioma","volume":"315","author":"Prey","year":"2016","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jaad.2020.04.013_bib21","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13052-017-0421-5","article-title":"Cardiac arrest in a toddler treated with propranolol for infantile hemangioma: a case report","volume":"43","author":"Tosoni","year":"2017","journal-title":"Ital J Pediatr"},{"issue":"4","key":"10.1016\/j.jaad.2020.04.013_bib22","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/pde.12869","article-title":"Adverse events in young and preterm infants receiving topical timolol for infantile hemangioma","volume":"33","author":"Frommelt","year":"2016","journal-title":"Pediatr Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2020.04.013_bib23","doi-asserted-by":"crossref","first-page":"e1589","DOI":"10.1542\/peds.2010-0077","article-title":"Hyperkalemia complicating propranolol treatment of an infantile hemangioma","volume":"126","author":"Pavlakovi\u0107","year":"2010","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.jaad.2020.04.013_bib24","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jaad.2014.12.019","article-title":"Is cardiovascular evaluation necessary prior to and during beta-blocker therapy for infantile hemangiomas? a cohort study","volume":"72","author":"Raphael","year":"2015","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962220305533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962220305533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:58:50Z","timestamp":1759273130000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962220305533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0190962220305533"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2020.04.013","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Limited utility of repeated vital sign monitoring during initiation of oral propranolol for complicated infantile hemangioma","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2020.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}